Business Context and Reporting Period
This Form 8-K is a current report filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on October 16, 2015, regarding events occurring on October 9, 2015. The filing details the results of the company's adjourned annual meeting of stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The primary event reported is the vote on Proposal 4, an amendment to the Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 30,000,000 to 60,000,000.
- Shares Entitled to Vote: 15,956,565
- Shares Present or Represented: 11,518,705
- Vote Tally:
- For: 7,967,461
- Against: 3,343,684
- Abstain: 207,560
While the proposal received 69% of the shares voted, it initially appeared to receive only 49.9% of the shares eligible to vote. Under Delaware law, approval requires at least 50% of the shares eligible to vote.
Outlook, Risks, and Contingencies
Contingency: Due to the preliminary vote falling just short of the 50% threshold of eligible shares, the company has requested an audit and verification of the votes by Broadridge Financial Solutions, Inc. The final voting results are pending and will be disclosed in an amendment to this Current Report.
Risk: There is a risk that the proposal to increase authorized shares may not be approved if the audit confirms the preliminary count.
Investor Verification Checklist
- Verify the final audited voting results once the amendment to this 8-K is filed.
- Confirm whether the 50% threshold of eligible shares was met after the vote audit.
- Check for subsequent filings regarding the amendment to the Restated Certificate of Incorporation.